Anticancer Pre–Screening of Sansevieria masoniana C. Using Brine Shrimp Lethality Assay

DOI

10.2991/assehr.k.210909.002How to use a DOI?

Keywords

Anticancer activity, BSLA, Sansevieria masoniana C

Abstract

A lot of detrimental side effects on cancer treatment, causing lately, the focus of cancer treatment now shifted toward natural products such as medical plants. Sansevieria masoniana C are medical plants which have a high antioxidant content. This study aimed to evaluate the anticancer potential of Sansevieria masoniana C. extract with a fast pre-screening method brine shrimp lethality assay (BSLA). This method measuring the LC50 of the of Sansevieria masoniana C. extract to the Artemia salina Leach Larvae that analog with the cancer cells. The result from Sansevieria masoniana C. extract shows that Sansevieria masoniana C. has potential anticancer activity with LC50 107,49 μg/mL. Sansevieria masoniana C. are products with excellent cytotoxicity and were promising sources for developing anticancer agents.

Copyright

© 2021, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - A. L. Mawardi
AU  - A. R. S. Siregar
AU  - Elfrida
PY  - 2021
DA  - 2021/09/11
TI  - Anticancer Pre–Screening of Sansevieria masoniana C. Using Brine Shrimp Lethality Assay
BT  - Proceedings of the 2nd International Conference on Science, Technology, and Modern Society (ICSTMS 2020)
PB  - Atlantis Press
SP  - 6
EP  - 9
SN  - 2352-5398
UR  - https://doi.org/10.2991/assehr.k.210909.002
DO  - 10.2991/assehr.k.210909.002
ID  - Mawardi2021
ER  -